Upsized and oversubscribed Series B financing brings healthcare and science focused venture capital Aims to support acceleration of clinical development of low-dose psilocybin in SUNHA and 5MeO-DMT in other neuro-psychiatric indications OXFORD, England–( BUSINESS WIRE)–Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through the novel application of…


Previous articlePsychedelic Medicine Virtual Symposium – 8/28, 9/11, 9/25
Next articlePsychedelic Bulletin: Compass Pathways Secures 5th Patent; atai to Develop Salvinorin A